Ares Capital Corporation (ARCC) Stock Price Today
Aura AI Summary
Key Stats
- $13.93BMarket Cap
- 4,867,194Volume
- FinancialsSector
- $21.5652W High
- $17.4552W Low
- 124 DaysTypical Hold Time
- $29.32BEnterprise Value
- 9.9%Div Yield
- -Trading Activity
Track Ares Capital Corporation (ARCC) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Ares Capital Corporation has traded between a low of $17.45 and a high of $21.56, highlighting its annual price range. Buy and sell Ares Capital Corporation shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Ares Capital Corporation
Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing primarily in U.S. middle-market companies with investment opportunities as well as in larger companies. Its portfolio comprises of first lien senior secured loans, second lien senior secured loans, and mezzanine debt (subordinated unsecured loan), which may include equity components that are diversified by industry and sector. The company may invest in preferred and common equity investments to a lesser proportion. Its revenue mainly consists of interest and dividend income received from the investment made.
Most Recent News
Class action lawsuit filed over Dun & Bradstreet merger alleging misleading shareholder info.
A class action lawsuit has been filed against Dun & Bradstreet Holdings, Inc. concerning its merger with Clearlake Capital Group affiliates. The suit alleges that Dun & Bradstreet provided false and misleading information in its merger announcement a...

Chinese biopharma stocks rise as US may ease drug licensing restrictions with China
Chinese biopharma stocks surged in Hong Kong after reports that the US Treasury is drafting rules to allow American pharmaceutical companies to continue licensing most drugs from Chinese firms, excluding sensitive biotech related to pathogens. This p...

60% of workers fear AI is eroding skills, with critical thinking most affected, says IBM study
A global IBM study reveals 60% of employees worry AI is diminishing their skills, especially critical thinking. While CHROs emphasize the need for judgment in AI oversight, employees rank it lower, highlighting a skills perception gap. Nearly half of...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.